Deutetrabenazine in the treatment of Huntington's disease

Richard, A; Frank, S

Frank, S (reprint author), Harvard Med Sch, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.

NEURODEGENERATIVE DISEASE MANAGEMENT, 2019; 9 (1): 31

Abstract

Deutetrabenazine (DTBZ) is a US FDA-approved treatment for chorea in Huntington's disease. The substitution of deuterium for hydrogen at specific posi......

Full Text Link